Clinical Trial

The Skin Microbiota in Skin Disease and Eczema

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Background: The skin microbiota influence skin health in several skin diseases and atopic dermatitis (AD). Presence of Staphylococcus have been associated to a sever course of the disease. Objectives: The aim of the study is to investigate the influence of bacteria, and the skin microbiota on the inflammation and skin barrier. Moreover, dysbiosis in the microbiota, the inflammation profile, the skin barrier damage will be related to objective and patient oriented measures. Importance: Knowledge of interactions between host defense, skin barrier and bacterial colonizing skin can facilitate development of new prevention and treatment strategies to control microbial impact in skin diseases and eczema.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-10.
Trial Details
NCT Number NCT06924333
Lead Sponsor Region Skane
Conditions Skin Disease, Eczema, Eczema Atopic Dermatitis
Enrollment 100 participants
Start Date 2025-01-20
Primary Completion 2027-11-20 (estimated)
Study Completion 2027-11-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-04